Literature DB >> 26210037

Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.

Naimat Kalim Bari1, Mohammad Fazil2, Md Quamrul Hassan3, Md Rafi Haider4, Bharti Gaba2, Jasjeet K Narang5, Sanjula Baboota2, Javed Ali6.   

Abstract

The present work discusses the preparation, characterization and in vivo evaluation of thiolated chitosan nanoparticles (TCS-NPs) of buspirone hydrochloride (BUH) for brain delivery through intranasal route. TCS NPs were prepared by ionic gelation method and characterized for various parameters. The NPs formed were having particle size of 226.7±2.52nm with PDI 0.483±0.031. Drug entrapment efficiency (EE) and loading capacity (LC) were found to be 81.13±2.8 and 49.67±5.5%. The cumulative percentage drug permeation through nasal mucosa was 76.21%. Bioadhesion study carried out on porcine mucin and showed a bioadhesion efficiency of 90.218±0.134%. Nose-to-brain delivery of placebo NPs was investigated by confocal laser scanning microscopy (CLSM) technique using rhodamine-123 as a marker. The brain concentration achieved after intranasal administration of TCS-NPs was 797.46±35.76ng/ml with tmax 120min which was significantly higher than achieved after intravenous administration on BUH solution 384.15±13.42ng/ml and tmax of 120min and intranasal administration of BUH solution 417.77±19.24ng/ml and tmax 60min.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Buspirone hydrochloride (BUH); General anxiety disorder; Intra nasal; Nanoparticles; Nose to brain; Thiolated chitosan

Mesh:

Substances:

Year:  2015        PMID: 26210037     DOI: 10.1016/j.ijbiomac.2015.07.041

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  9 in total

Review 1.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

Review 2.  Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System.

Authors:  Doddy Denise Ojeda-Hernández; Alejandro A Canales-Aguirre; Jorge Matias-Guiu; Ulises Gomez-Pinedo; Juan C Mateos-Díaz
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05

3.  Similarity Evaluation on the Compound TCM Formulation "Huoling Shengji Granule" and Its Placebo by Intelligent Sensory Evaluation Technologies and the Human Sensory Evaluation Method Based on Critical Quality Attributes.

Authors:  Mei Wu; Chengjie Guo; Ning Guo; Tianyi Zhang; Youjie Wang; Yuan Wang; Xiao Lin; Fei Wu; Yi Feng
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

Review 4.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

Review 5.  Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.

Authors:  Nathalie Hock; Giuseppe Francesco Racaniello; Sam Aspinall; Nunzio Denora; Vitaliy V Khutoryanskiy; Andreas Bernkop-Schnürch
Journal:  Adv Sci (Weinh)       Date:  2021-11-12       Impact factor: 16.806

Review 6.  Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa.

Authors:  Stella Gänger; Katharina Schindowski
Journal:  Pharmaceutics       Date:  2018-08-03       Impact factor: 6.321

Review 7.  Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.

Authors:  Yana Zorkina; Olga Abramova; Valeriya Ushakova; Anna Morozova; Eugene Zubkov; Marat Valikhov; Pavel Melnikov; Alexander Majouga; Vladimir Chekhonin
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

Review 8.  Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier.

Authors:  David Lee; Tamara Minko
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

Review 9.  Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System.

Authors:  Tyler P Crowe; Walter H Hsu
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.